Telehealth Virtual Visits Software is Launched by Seattle Based MedBridge

The offer is intended to provide crucial help to healthcare organizations and their patients throughout the COVID-19 crisis by allowing providers to manage the care of their patients remotely.

Healthcare organizations and professionals across the care continuum are now being confronted with equally difficult challenges. Many outpatient organizations are experiencing steep revenue loss as patients cancel or defer appointments due to quarantine, social distancing protocols, and concerns overexposure. Post-acute care clients, including those in skilled nursing and home health, must adjust care delivery to keep both their staff and patients safe. In response, MedBridge launched its Telehealth solution to be available as a beta version several months sooner than planned.

MedBridge is here to support our customers, their patients, and their communities during this challenging time and beyond. We’re committed to helping everyone weather this crisis and stay prepared during every stage with innovative solutions for remote care and education as we all adjust to a new paradigm,” said Justin Kowalchuk, CEO, and founder of MedBridge.

MedBridge Telehealth allows providers to remotely screen, triage, and care for patients in real-time, providing a HIPAA-compliant method for continuing treatment plans during the ongoing COVID-19 crisis. Providers can also foster rapport, engagement, and education by building, sharing, and discussing targeted home exercises with their patients during each virtual visit.

“Telehealth Virtual Visits offers a patient experience that’s as close as possible to an in-person session. It’s easy to implement, use, and learn for clinicians and patients, which is essential now that healthcare professionals are in crisis mode. Because it allows for uninterrupted care, it can be used to optimize long-term outcomes by rehab providers across the care continuum,” said Keta Shaw, Telehealth Product Manager, MedBridge.

The Virtual Visit software is part of the complete MedBridge Digital Patient Engagement Suite, which includes program adherence tracking, in-app messaging, and satisfaction monitoring to help patients self-manage and stay active in their plan of care while they’re confined to their home. The virtual patient care solution, paired with MedBridge’s remote training, infection prevention, and crisis management education, offers healthcare organizations a complete solution to combat the challenges of this time.

SourceMedBridge
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version